Bandingkan Harga & Kinerja Lupromax Pelumas Indonesia Tbk. (LMAX) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Lupromax Pelumas Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Lupromax Pelumas Indonesia Tbk. diperdagangkan di Rp106 (kapitalisasi pasar 73,45 M, volume 24 jam 520,4 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| LMAX | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 73,45 M | 104,4 M |
Volume | 520,4 rb | — |
Lot | 5,2 rb | — |
Perputaran | 55,39 jt | — |
Harga Rata-rata | 106,43 | — |
Nilai Transaksi | 55,39 jt | — |
Harga Ekuilibrium Indikatif | 106 | — |
Volume Ekuilibrium Indikatif | 90 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Lupromax Pelumas Indonesia Tbk.
PT Lupromax Pelumas Indonesia Tbk formerly PT Karya Pelumas Indonesia (the Company) was established based on Notarial Deed No. 42 dated February 27, 2017 of Meissie Pholuan, S.H., notary in Jakarta. The Company started its commercial operations in 2017.
Selengkapnya di halaman LMAX →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
